|
|||||
|
|
The TEL-AML1 real-time quantitative polymerase chain reaction (PCR) might replace the antigen receptor-based genomic PCR in clinical minimal residual disease studies in children with acute lymphoblastic leukaemia |
|
| Authors: | de Haas V Breunis W B Dee R Verhagen O J H M Kroes W van Wering E R van Dongen J J M van den Berg H van der Schoot C E |
| Affiliation: | Central Laboratory of the Netherlands Blood Transfusion Service and Laboratory of Experimental and Clinical Immunology, Academic Medical Centre, Amsterdam, The Netherlands. |
| Abstract: | |
| Keywords: | acute lymphoblastic leukaemia (ALL) T‐cell receptor (TCR) genes minimal residual disease (MRD) RQ‐PCR TEL‐AML1 |
| 本文献已被 PubMed 等数据库收录！ | |